Trial intelligence / Profile preview

Daprodustat in Japanese Hemodialysis Patients with Anemia

NCT02019719Phase 2Completed

Sponsor
GSK
Start
Nov 2013
Primary completion
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of daprodustat in anemia of chronic kidney disease (CKD-A), sponsored by GSK. Started Nov 2013; status: completed.

02

Drugs

daprodustat
03

Conditions

anemia of chronic kidney disease (CKD-A)

Beyond the preview

Go deeper on NCT02019719.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02019719.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call